137 related articles for article (PubMed ID: 25337130)
1. The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer.
Karlsson L; Thunberg P; Johansson B; Persliden J
J Contemp Brachytherapy; 2014 Oct; 6(3):282-8. PubMed ID: 25337130
[TBL] [Abstract][Full Text] [Related]
2. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy.
Hsu IC; Lessard E; Weinberg V; Pouliot J
Brachytherapy; 2004; 3(3):147-52. PubMed ID: 15533807
[TBL] [Abstract][Full Text] [Related]
3. Improving the dosimetric coverage of interstitial high-dose-rate breast implants.
Kestin LL; Jaffray DA; Edmundson GK; Martinez AA; Wong JW; Kini VR; Chen PY; Vicini FA
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):35-43. PubMed ID: 10656370
[TBL] [Abstract][Full Text] [Related]
4. SU-E-T-430: Evaluation of Inverse Optimization in Brachytherapy for Locally Advanced Cervix Cancer.
Liao Y; Dandekar V; Chu J; Turian J; Kiel K
Med Phys; 2012 Jun; 39(6Part16):3803. PubMed ID: 28517217
[TBL] [Abstract][Full Text] [Related]
5. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate.
Lachance B; Béliveau-Nadeau D; Lessard E; Chrétien M; Hsu IC; Pouliot J; Beaulieu L; Vigneault E
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):86-100. PubMed ID: 12182978
[TBL] [Abstract][Full Text] [Related]
6. Impact of inter-observer variations in target volume delineation on dose volume indices for accelerated partial breast irradiation with multi-catheter interstitial brachytherapy.
Upreti RR; Budrukkar A; Upreti U; Wadasadawala T; Misra S; Gurram L; Pathak R; Deshpande DD
Radiother Oncol; 2018 Oct; 129(1):173-179. PubMed ID: 30318170
[TBL] [Abstract][Full Text] [Related]
7. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.
Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P
Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.
White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy.
Edmundson GK; Yan D; Martinez AA
Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1257-63. PubMed ID: 7493850
[TBL] [Abstract][Full Text] [Related]
11. Role of step size and max dwell time in anatomy based inverse optimization for prostate implants.
Manikandan A; Sarkar B; Rajendran VT; King PR; Sresty NV; Holla R; Kotur S; Nadendla S
J Med Phys; 2013 Jul; 38(3):148-54. PubMed ID: 24049323
[TBL] [Abstract][Full Text] [Related]
12. Dwell time modulation restrictions do not necessarily improve treatment plan quality for prostate HDR brachytherapy.
Balvert M; Gorissen BL; den Hertog D; Hoffmann AL
Phys Med Biol; 2015 Jan; 60(2):537-48. PubMed ID: 25549084
[TBL] [Abstract][Full Text] [Related]
13. 3D source tracking and error detection in HDR using two independent scintillator dosimetry systems.
Linares Rosales HM; Johansen JG; Kertzscher G; Tanderup K; Beaulieu L; Beddar S
Med Phys; 2021 May; 48(5):2095-2107. PubMed ID: 33222208
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
15. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
Nickers P; Lenaerts E; Thissen B; Deneufbourg JM
Radiother Oncol; 2005 Feb; 74(2):131-6. PubMed ID: 15734200
[TBL] [Abstract][Full Text] [Related]
16. Autoactivation of source dwell positions for HDR brachytherapy treatment planning.
Giannouli S; Baltas D; Milickovic N; Lahanas M; Kolotas C; Zamboglou N; Uzunoglu N
Med Phys; 2000 Nov; 27(11):2517-20. PubMed ID: 11128303
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
[TBL] [Abstract][Full Text] [Related]
19. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.
Vicini FA; Kestin LL; Edmundson GK; Jaffray DA; Wong JW; Kini VR; Chen PY; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):803-10. PubMed ID: 10524437
[TBL] [Abstract][Full Text] [Related]
20. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
Morton GC; Sankreacha R; Halina P; Loblaw A
Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
